Lupin Strikes Deal For Anti-TB Drug Pretomanid
Company Plans To Commercialize Highly-Drug Resistant TB Medicine In 140 Countries
Lupin and non-profit organization TB Alliance have entered into a partnership for a new therapy for highly drug-resistant tuberculosis, pretomanid, to be distributed in 140 countries and territories.
